The Calorie Chain Reaction: Ozempic and the Future of Consumption
Everyone is talking about what Ozempic does to the human body.
Almost nobody is talking about what it does to the economy.
In this episode of The Honest Catapult, we explore the surprising chain reaction triggered by the rapid adoption of GLP-1 drugs such as Ozempic and Wegovy. What begins as a medical breakthrough quickly becomes a story about consumer behavior, delivery platforms, restaurants, labor markets, digital services, and the future of economic growth.
Using Mexico's intensifying food-delivery wars as a starting point, we examine how companies are already adapting to a world where millions of people may eat differently, shop differently, and make different decisions about health and consumption.
This is a story of impact, the butterfly effect: Because when human behavior changes at scale, entire industries are forced to evolve.
In this episode:
• Why GLP-1 drugs could become one of the most important economic forces of the decade
• How Ozempic is influencing food delivery, restaurants, and consumer spending
• Why Mexico may become a testing ground for the post-obesity economy
• The hidden connection between health, technology, apps, and economic growth
• What business leaders, marketers, and investors should be watching next
• The power of second-order effects and systems thinking
If you enjoy economics, business strategy, technology, behavioral science, and unconventional perspectives on the future, this episode is for you.
Subscribe to The Honest Catapult for thought-provoking conversations about the forces quietly reshaping our world.
Chapters:
00:00 Introduction: The Economic Story Nobody Is Talking About
01:15 Why Ozempic Is Bigger Than Weight Loss
03:05 The Economics of Appetite
05:10 Mexico's Food Delivery Battleground
07:20 How Delivery Apps Are Adapting
09:10 The Consumer Behavior Revolution
11:05 Winners and Losers in the GLP-1 Economy
13:05 Health, Technology, and Economic Growth
15:05 The Power of Second-Order Effects
17:00 What Happens Next?
18:05 Final Thoughts